Koninklijke Philips NV
MIL:PHIA
Koninklijke Philips NV
Research & Development
Koninklijke Philips NV
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
Research & Development
-€1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
O
|
ONWARD Medical NV
XBRU:ONWD
|
Research & Development
-€17.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Koninklijke Philips NV
Glance View
Koninklijke Philips NV, more commonly known as Philips, has transformed itself from its origins as a humble light bulb manufacturer in 1891 into a global leader in health technology. The company, headquartered in Amsterdam, embodies innovation and resilience, consistently reinventing itself to meet the needs of an ever-evolving world. Throughout the 20th century, Philips expanded its portfolio, venturing into consumer electronics, from televisions to audio equipment, earning it household recognition around the globe. However, the brand's recent strategic pivot towards focusing primarily on health technology is a testament to its agile vision for long-term growth and sustainability. Today, Philips operates through several key segments: Diagnosis & Treatment, Connected Care, and Personal Health. The company generates the bulk of its revenues by offering sophisticated medical imaging systems, patient monitoring solutions, and consumer health products. Its diagnostic imaging tools, like MRI and CT scanners, play a crucial role in the early detection of diseases, while its patient monitoring solutions ensure continuous care both in hospitals and remotely. Meanwhile, the personal health division supplies consumers with products designed to promote well-being, such as electronic toothbrushes and personal grooming devices. Through a strong commitment to innovation and a focus on healthcare outcomes, Philips continues to carve out its niche as a pivotal player in health technology, effectively bridging the gaps between technology and wellness.
See Also
What is Koninklijke Philips NV's Research & Development?
Research & Development
-1.8B
EUR
Based on the financial report for Mar 31, 2024, Koninklijke Philips NV's Research & Development amounts to -1.8B EUR.
What is Koninklijke Philips NV's Research & Development growth rate?
Research & Development CAGR 10Y
-1%
Over the last year, the Research & Development growth was 17%.